Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

• Главные авторы: Maria Rubinstein (Автор), Darragh Halpenny (Автор), Vicky Makker (Автор), Rachel N. Grisham (Автор), Carol Aghajanian (Автор), Karen Cadoo (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2019-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with recurrent EC may benefit from further platinum-based...